BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38200385)

  • 21. A risk grouping algorithm for predicting factors of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Micoogullari U; Cakici MC; Kisa E; Canda AE; Kilic FU; Ardicoglu A; Altinova S; Atmaca AF; Akbulut Z; Balbay MD
    Int J Clin Pract; 2021 Oct; 75(10):e14495. PubMed ID: 34155724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy.
    Hong JH; Kwon YS; Kim IY
    Asian J Androl; 2017; 19(6):700-706. PubMed ID: 28230003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
    Fujita N; Koie T; Hashimoto Y; Narita T; Tobisawa Y; Tanaka T; Noro D; Oikawa M; Hagiwara K; Yoneyama T; Imai A; Yamamoto H; Hatakeyama S; Yoneyama T; Ohyama C
    Int Urol Nephrol; 2018 Nov; 50(11):1999-2005. PubMed ID: 30229466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
    Galiabovitch E; Hovens CM; Peters JS; Costello AJ; Battye S; Norden S; Ryan A; Corcoran NM
    BJU Int; 2017 Apr; 119(4):567-572. PubMed ID: 27431748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years.
    Sooriakumaran P; Haendler L; Nyberg T; Gronberg H; Nilsson A; Carlsson S; Hosseini A; Adding C; Jonsson M; Ploumidis A; Egevad L; Steineck G; Wiklund P
    Eur Urol; 2012 Nov; 62(5):768-74. PubMed ID: 22633365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of lymphovascular invasion in patients with prostate cancer following radical prostatectomy and its association with their clinicopathological features: An updated PRISMA-compliant systematic review and meta-analysis.
    Jiang W; Zhang L; Wu B; Zha Z; Zhao H; Jun Y; Jiang Y
    Medicine (Baltimore); 2018 Dec; 97(49):e13537. PubMed ID: 30544460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
    Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nomogram Predicting Locally Advanced Prostate Cancer in Patients with Clinically Organ-Confined Disease Who Underwent Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
    Kawase M; Goto T; Ebara S; Tatenuma T; Sasaki T; Ishihara T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Kobayashi T; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Ann Surg Oncol; 2023 Oct; 30(11):6925-6933. PubMed ID: 37338747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
    Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
    BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oncological outcomes between retropubic radical prostatectomy and robot-assisted radical prostatectomy: an analysis stratified by surgical experience.
    Park J; Yoo DS; Song C; Park S; Park S; Kim SC; Cho Y; Ahn H
    World J Urol; 2014 Feb; 32(1):193-9. PubMed ID: 24062092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study.
    Wang F; Liang J; Yang F; Liu F; Han S; Xing N
    Front Endocrinol (Lausanne); 2022; 13():1020655. PubMed ID: 36313761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis.
    Bhat KRS; Covas Moschovas M; Sandri M; Noel J; Reddy S; Perera R; Rogers T; Roof S; Patel VR
    Eur Urol Focus; 2022 Sep; 8(5):1192-1197. PubMed ID: 34736871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
    Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
    Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of perineural invasion, lymphovascular invasion, and high-grade prostatic intraepithelial neoplasia in robot-assisted laparoscopic radical prostatectomy.
    Jung JH; Lee JW; Arkoncel FR; Cho NH; Yusoff NA; Kim KJ; Song JM; Kim SJ; Rha KH
    Ann Surg Oncol; 2011 Dec; 18(13):3828-32. PubMed ID: 21660497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of selective nerve sparing in high risk prostate cancer during robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Bates AS; Mouraviev V; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Jun; 11(2):129-138. PubMed ID: 27435701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Lymphovascular Invasion on Overall Survival in Patients With Prostate Cancer Following Radical Prostatectomy: Stage-per-Stage Analysis.
    Jamil M; Rakic N; Sood A; Keeley J; Modonutti D; Novara G; Jeong W; Menon M; Rogers CG; Abdollah F
    Clin Genitourin Cancer; 2021 Oct; 19(5):e319-e325. PubMed ID: 34154946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy.
    Bravi CA; Dell'Oglio P; Mazzone E; Moschovas MC; Falagario U; Piazza P; Scarcella S; Bednarz C; Sarchi L; Tappero S; Knipper S; De Groote R; Sjoberg D; Schiavina R; Suardi N; Terrone C; Autorino R; Carrieri G; Galosi A; Galfano A; Briganti A; Montorsi F; Patel V; Vickers A; Mottrie A
    Eur Urol Oncol; 2023 Aug; 6(4):414-421. PubMed ID: 35850976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of margin status at 37 months after robot assisted radical prostatectomy.
    Warner JN; Nunez RN; Mmeje CO; Colby TV; Ferrigni RG; Humphreys MR; Andrews PE; Castle EP
    Can J Urol; 2011 Dec; 18(6):6043-9. PubMed ID: 22166333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.